GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MannKind Corp (STU:NNFN) » Definitions » Accounts Payable

MannKind (STU:NNFN) Accounts Payable : €4.7 Mil (As of Mar. 2025)


View and export this data going back to . Start your Free Trial

What is MannKind Accounts Payable?

MannKind's Accounts Payable for the quarter that ended in Mar. 2025 was €4.7 Mil.

MannKind's quarterly Accounts Payable increased from Sep. 2024 (€5.8 Mil) to Dec. 2024 (€6.5 Mil) but then declined from Dec. 2024 (€6.5 Mil) to Mar. 2025 (€4.7 Mil).

MannKind's annual Accounts Payable declined from Dec. 2022 (€10.4 Mil) to Dec. 2023 (€8.8 Mil) and declined from Dec. 2023 (€8.8 Mil) to Dec. 2024 (€6.5 Mil).


MannKind Accounts Payable Historical Data

The historical data trend for MannKind's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MannKind Accounts Payable Chart

MannKind Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.59 6.16 10.43 8.79 6.49

MannKind Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.58 8.88 5.81 6.49 4.66

MannKind Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


MannKind Accounts Payable Related Terms

Thank you for viewing the detailed overview of MannKind's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


MannKind Business Description

Traded in Other Exchanges
Address
1 Casper Street, Danbury, CT, USA, 06810
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

MannKind Headlines

No Headlines